Buprenorphine: "field trials" of a new drug.
Buprenorphine is being introduced as a new treatment drug for narcotics addiction in the United States. The authors were asked by the National Institute on Drug Abuse to conduct a field trial to determine if buprenorphine might play a role in street markets. Because no street use of the drug existed in the United States, the authors used three sources of information: (a) "street readings" of clinical studies, (b) Internet discussion lists, and (c) research in other countries. By using an emergent style of analysis that relies on replication of patterns across disparate data sources, it was determined that buprenorphine has desirable characteristics from a street addict point of view. An evaluation of the field trial 5 years later evaluates its accuracy.
Agar
M
M
Department of Anthropology, History and Social Medicine, University of San Francisco's School of Medicine, USA. magar@anth.umd.edu
Bourgois
P
P
French
J
J
Murdoch
O
O
D015706:Bibliometrics; D002047:Buprenorphine / Q000627:therapeutic use*; D005544:Forecasting; D006801:Humans; D013287:Illicit Drugs; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011336:Probability; D014481:United States
D013287:Illicit Drugs; D009292:Narcotic Antagonists; D002047:Buprenorphine